基本信息
浏览量:122
职业迁徙
个人简介
Prof. Jamie Rossjohn’s research is centred on an understanding immunity. He is currently a NHMRC Investigator L3 Fellow (2022-26) and previously an ARC Australian Laureate Fellow (2017-21), NHMRC Australia Fellow (2011-16) and ARC Federation Fellow (2007-11). He was the former Head of the Infection and Immunity Program (2016-19) of the Biomedicine Discovery Institute. In 2022, Prof. Rossjohn was elected as a Fellow of the Royal Society and Associate Member of EMBO.
Prof. Rossjohn is known for his contributions to the understanding the molecular basis underpinning immunity. He has used structural biology to explain pre-T- cell receptor (TCR) self-association in T-cell development, and how the TCR specifically recognises polymorphic Human Leukocyte Antigen (HLA) molecules in the context of viral immunity and aberrant T- cell reactivity.
He has unearthed structural mechanisms of HLA polymorphism impacting on drug and food hypersensitivities, as well as Natural Killer cell receptor recognition. He has pioneered our molecular understanding of lipid-based immunity by T cells, revealing that it can differ fundamentally from peptide-mediated adaptive immunity.
Recently he has provided a structural basis of how vitamin B metabolites can be presented and recognised by the immune system, revealing a new class of antigen. Collectively, he has published > 465 papers and mentored numerous researchers towards obtaining higher degrees and nationally competitive fellowships.
Prof. Rossjohn is known for his contributions to the understanding the molecular basis underpinning immunity. He has used structural biology to explain pre-T- cell receptor (TCR) self-association in T-cell development, and how the TCR specifically recognises polymorphic Human Leukocyte Antigen (HLA) molecules in the context of viral immunity and aberrant T- cell reactivity.
He has unearthed structural mechanisms of HLA polymorphism impacting on drug and food hypersensitivities, as well as Natural Killer cell receptor recognition. He has pioneered our molecular understanding of lipid-based immunity by T cells, revealing that it can differ fundamentally from peptide-mediated adaptive immunity.
Recently he has provided a structural basis of how vitamin B metabolites can be presented and recognised by the immune system, revealing a new class of antigen. Collectively, he has published > 465 papers and mentored numerous researchers towards obtaining higher degrees and nationally competitive fellowships.
研究兴趣
论文共 751 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The FEBS journalno. 7 (2024): 1530-1544
ISCIENCEno. 2 (2024): 108801-108801
Lisa Ciacchi, Jeffrey Y.W. Mak, Jeremy P. Le,David P. Fairlie,James McCluskey,Alexandra J. Corbett,Jamie Rossjohn,Wael Awad
Journal of Biological Chemistrypp.107229-107229, (2024)
Proceedings of the National Academy of Sciences of the United States of Americano. 9 (2024): e2315985121-e2315985121
Emi Ito,Shinsuke Inuki,Yoshihiro Izumi,Masatomo Takahashi, Yuki Dambayashi,Lisa Ciacchi,Wael Awad, Ami Takeyama,Kensuke Shibata,Shotaro Mori, Jeffrey Y. W. Mak,David P. Fairlie,
SCIENCE IMMUNOLOGYno. 91 (2024): eade6924-eade6924
IMMUNOLOGY AND CELL BIOLOGY (2024)
JOURNAL OF BIOLOGICAL CHEMISTRYno. 7 (2023): 104930-104930
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn